You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials

Article info

Article menu
XML
Coronary artery disease
Original research
Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials

Authors

  • Anda Bularga BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Mohammed N Meah BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Dimitrios Doudesis BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Anoop S V Shah Department of Non-Communicable Diseases, London School of Hygiene and Tropical Medicine, London, UKDepartment of Cardiology, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Nicholas L Mills BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UKUsher Institute, University of Edinburgh Division of Health Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  • David E Newby BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Kuan Ken Lee BHF Centre for Cardiovascular Science, University of Edinburgh Division of Clinical and Surgical Sciences, Edinburgh, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Anda Bularga; anda.bularga{at}ed.ac.uk
View Full Text

Citation

Bularga A, Meah MN, Doudesis D, et al
Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials
Open Heart 2021;8:e001707. doi: 10.1136/openhrt-2021-001707

Publication history

  • Received April 29, 2021
  • Accepted July 13, 2021
  • First published August 2, 2021.
Online issue publication 
July 11, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.